Covered recipient · General Payments record
LAURIE S FINGER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Pediatrics, Critical Care
General Payments · PY2021–2023
$1,230.36
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $442.49 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $275.93 | 6 |
| ABBVIE INC. | $52.04 | 3 |
| Ultragenyx Pharmaceutical Inc. | $21.34 | 1 |
| Rhythm Pharmaceuticals, Inc. | $18.72 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.84 | 1 |
| Novo Nordisk AS | $16.52 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.74 | 1 |
| Kyowa Kirin, Inc. | $13.17 | 1 |
| Eton Pharmaceuticals, Inc. | $12.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.56 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004037417 | CMS |
| ABBVIE INC. | $15.91 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004037423 | CMS |
| ABBVIE INC. | $17.57 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004037431 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.84 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016979529 | CMS |
| Dexcom, Inc. | $106.58 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054759513 | CMS |
| Dexcom, Inc. | $11.54 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054759497 | CMS |
| Dexcom, Inc. | $13.50 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054759505 | CMS |
| Dexcom, Inc. | $61.13 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054759489 | CMS |
| Dexcom, Inc. | $79.05 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054759521 | CMS |
| Dexcom, Inc. | $4.13 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054759529 | CMS |
| Eton Pharmaceuticals, Inc. | $12.19 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1039005559 | CMS |
| Kyowa Kirin, Inc. | $13.17 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1027043411 | CMS |
| Novo Nordisk Inc | $16.52 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000838357 | CMS |
| Rhythm Pharmaceuticals, Inc. | $18.72 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051220261 | CMS |
| Ultragenyx Pharmaceutical Inc. | $21.34 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059051703 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.74 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056555561 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.